Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
FibroBiologics, Inc. - Common Stock
(NQ:
FBLG
)
1.380
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about FibroBiologics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
FibroBiologics Announces Closing of $3 Million Public Offering
April 02, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
Which stocks are moving before the opening bell on Wednesday?
↗
April 01, 2026
Via
Chartmill
FibroBiologics Announces Pricing of $3 Million Public Offering
March 31, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
Top movers in Tuesday's after hours session
↗
March 31, 2026
Via
Chartmill
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
March 31, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
March 31, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Tuesday?
↗
March 31, 2026
Via
Chartmill
The market is filled with gapping stocks in Tuesday's session.
↗
March 31, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's after-hours session.
↗
March 25, 2026
Via
Chartmill
FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement
March 25, 2026
Reverse Split Expected to Take Effect March 30, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
March 18, 2026
AVAI, FBLG, FATE, MESO, and LGVN as Regenerative Medicine Moves From Lab to GMP Manufacturing Facilities
From
USA News Group
Via
GlobeNewswire
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
March 12, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
March 05, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
March 02, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics to Present at the BIO Investment & Growth Summit
February 26, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
February 24, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Granted Extension by Nasdaq to Regain Compliance
February 23, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
Get insights into the top gainers and losers of Wednesday's after-hours session.
↗
February 18, 2026
Via
Chartmill
FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University
February 10, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
February 05, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics to Present at the DealFlow Discovery Conference
January 20, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics CEO Issues Letter to Shareholders
January 07, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
January 06, 2026
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
January 05, 2026
FSdC demonstrated statistically significant and superior improvement in disc preservation and structural integrity compared to other treatments
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
December 31, 2025
From
FibroBiologics, Inc.
Via
GlobeNewswire
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 16, 2025
From
FibroBiologics, Inc.
Via
GlobeNewswire
Monday's session: top gainers and losers
↗
December 15, 2025
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Which stocks are gapping on Monday?
↗
December 15, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Monday's pre-market session: top gainers and losers
↗
December 15, 2025
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 15, 2025
From
FibroBiologics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
